|
|
Article: Meditor Pharmaceuticals (North American) Ltd. announces the closing of a merger agreement with American Medical Technologies, Inc.
- Article from:
- Blood Weekly
- Article date:
- March 26, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Meditor Pharmaceuticals Ltd (Trading as M20.F) is pleased to announce it has concluded a merger agreement with AMERICAN MEDICAL TECHNOLOGIES, INC. (AMT) (see also Clinical Trial Research).
AMERICAN MEDICAL TECHNOLOGIES, INC. is a U.S. based company which performs biomedical research dedicated to the development and commercialization of proprietary Blood Cell Morphometric Method (BCMM) technology. Its purpose is to detect early cancer in patients where traditional methods do not work.
As a result of the continuous scientific research activity since 1985 a comprehensive Patent was filed in Russia for a "Method for diagnosing human tumor disorders".